You are viewing an incomplete version of our website. Please click to reload the website as full version.

Purinergic Receptor P2x, Ligand-Gated Ion Channel, 3 (P2RX3) (Cytoplasmic Domain) antibody

Details for Product No. ABIN350695, Supplier: Log in to see
Antigen
  • P2X3
  • P2RX3
  • 4930513E20Rik
Epitope
Cytoplasmic Domain
25
15
13
9
2
2
1
1
1
Reactivity
Human
52
28
22
2
Host
Rabbit
57
2
2
Clonality
Polyclonal
Conjugate
Un-conjugated
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (IHC), Western Blotting (WB)
42
17
17
11
10
6
5
4
4
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen A synthetic peptide from the cytoplasmic domain of human P2X3 (P2RX3, P2X purinoceptor 3, ATP receptor) conjugated to an immunogenic carrier protein was used as the antigen. The peptide shares 85% identity with rat and mouse sequence.
Specificity Specific for P2RX3.
Purification Whole serum
Alternative Name P2RX3 (P2RX3 Antibody Abstract)
Background Function: Receptor for ATP that acts as a ligand gated ion channel.
Subcellular location: Membrane, Multi-pass membrane protein. Also known as: P2RX3, P2X purinoceptor 3, ATP receptor, Purinergic receptor.
Application Notes A dilution of 1 : 300 to 1 : 2000 is recommended.
The optimal dilution should be determined by the end user.
Not yet tested in other applications.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage 4 °C/-20 °C
Storage Comment Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date 12 months
Background publications Garcia-Guzman, Soto, Gomez-Hernandez et al.: "Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue." in: Molecular pharmacology, Vol. 51, Issue 1, pp. 109-18, 1997 (PubMed).